Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Hydroxynorketamine for the use in the treatment of depression

Hydroxynorketamine for the use in the treatment of depression

US Patent 11723883 · Granted Aug 15, 2023

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for treatment of depression with oral dosage forms of ketamine2025
Hydroxynorketamine for the use in the treatment of depression2025
Method for treating depression2021
Oral dosage forms of ketamine2019
Method and composition for the treatment of opioid induced constipation2018
Naloxone single agent and multilayer tablets2018
Naloxone mono preparation and multilayer tablet2016
Controlled release oral dosage form comprising oxycodone2016
Pharmaceutical dosage form2014